🧪 Lab Sheet: Hepion to Debut on OTCQB Venture Market June 25 as “HEPA”

iBio (IBIO) reports its engineered amylin-receptor antibody slashed food intake 60% in obese-mouse trials, matching advanced DACRA peptide results.

Brooks Dyroff & Casimir Stone

Jun 26, 2025